Welcome to Dividend.com. Please help us personalize your experience.

Select the one that best describes you

Your personalized experience is almost ready.

Join other Individual Investors receiving FREE personalized market updates and research. Join other Institutional Investors receiving FREE personalized market updates and research. Join other Financial Advisors receiving FREE personalized market updates and research.

Thank you!

Check your email and confirm your subscription to complete your personalized experience.

Thank you for your submission, we hope you enjoy your experience


Best Dividend Stocks
Ex-Dividend Dates
High Yield Stocks
Screener
Strategies
Tools
Articles
Premium
Advisors
Guaranteed Income

BiotechStock Image

News

What? Biotech Stocks for Dividends?

Aaron Levitt Jun 22, 2016


When investors think of biotech stocks, the word “lottery” comes to mind. And for the most part, they are right. The vast bulk of the sector made up of smaller, early-stage drug developers with only one, or maybe two, new therapies in development. These firms live or die by how one drug performs. Fail the first round of a clinical trial and the stock is done for. Make it past the FDA’s watch and the stock soars.

A “lottery ticket” is certainly an accurate comparison when it comes to investing in biotech.

To read the Full Story, Go Premium or Log in

Popular Articles